SmithKline Beecham Collaborates with NIH

ISBN-10: 1569277125
ISBN-13: 9781569277126
Category: Pharmaceutical industry
Pages: 8
Language: English
Published: 1995
Publisher: Georgetown University, School of Foreign Service
Authors: Michael Patrick Ryan, Farahnaz Khandakar

Get the book

Similar books

The Hidden Epidemic: Confronting Sexually Transmitted Diseases
By Institute of Medicine, Committee on Prevention and Control of Sexually Transmitted Diseases
The book identifies the components of an effective national STD prevention and control strategy and provides direction for an appropriate response to the epidemic.
Ending Neglect: The Elimination of Tuberculosis in the United States
By Institute of Medicine, Division of Health Promotion and Disease Prevention, Committee on the Elimination of Tuberculosis in the United States
The panel also focuses on how to mobilize policy makers and the public to effective action. The book provides important background on the pathology of tuberculosis, its history and status in the U.S., and the public and private response.
Vaccines: A Biography
By Andrew W. Artenstein
Yet these are not ‘biographies’ in the traditional sense; they do not trace an individual’s growth and development. These are epic stories of discovery, of risk-takers.
Malaria: Obstacles and Opportunities
By Institute of Medicine, Division of International Health, Committee for the Study on Malaria Prevention and Control
This book examines the prospects for bringing malaria under control, with specific recommendations for U.S. policy, directions for research and program funding, and appropriate roles for federal and international agencies and the medical ...
Orphans and Incentives: Developing Technology to Address Emerging Infections
By Institute of Medicine, Forum on Emerging Infections
This book, a report from a Forum on Emerging Infections workshop, focuses on product areas where returns from the market might be perceived as being too small or too complicated by other factors to compete in industrial portfolios with ...
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop Summary
By Institute of Medicine, Division of Health Sciences Policy, Forum on Emerging Infections
It highlights ways in which managed care systems can aid research, develop clinical guidelines, manage the use of antibiotics, support public education efforts, and monitor the spread of emerging infections and microbial resistance.
Synthetic Biology: Science, Business, and Policy
By Lewis D. Solomon
A patent provides the inventor with exclusive rights for a limited time period in exchange for publicly disclosing the details of an invention so that others may use their information. A patent affords the inventor with legal protection ...
Principles and Practice of Clinical Research
By John I. Gallin, Frederick P Ognibene, Laura Lee Johnson
NIH historically has provided advice and guidance on COI for its employees for many years and updated its “Guide to Avoiding Financial and Non-Financial Conflicts or Perceived Conflicts of Interest in Clinical Research at NIH” (Guide) ...
Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary
By Institute of Medicine, Board on Health Sciences Policy, Board on Global Health
Emerging infectious disease threats that may not have available treatments or vaccines can directly affect the security of the world's health since these diseases also know no boundaries and will easily cross borders.
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
By Institute of Medicine, Medical Follow-up Agency, Committee on a Strategy for Minimizing the Impact of Naturally Occurring Infectious Diseases of Military Importance: Vaccine Issues in the U.S. Military
Protecting Our Forces reviews the process by which the U.S. military acquires vaccines to protect its warfighters from natural infectious disease threats.